AccuraGen China Participated in the Campaign against 2019-nCoV
Shanghai Yunsheng Medical Laboratory (fully owned subsidiary of AccuraGen Holdings), participated in the campaign against 2019-nCoV on February 2nd, together with other 131 corporations.
The campaign, called ‘Against Epidemic and Anti-Virus Joint Action’, aimed at integrating industrial and entrepreneurial elites to control the 2019-nCoV epidemic.
Shanghai Yunsheng Medical Laboratory was licensed by Chinese government and was certificated by CAP in the beginning of 2018. It boosts qualified sequencing machines, real-time PCR instruments and technicians for 2019-nCoV nucleic acid testing.
We embrace the spirit of fraternity and professionalism at this moment and are willing to provide testing services and professional volunteers to this campaign concerning the fate of all human beings.